Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ozeele Plus (also marketed as Dr. Gil Ozeele Plus) is a specialized dietary supplement formulated to support female fertility, regulate hormonal balance, and manage symptoms of polycystic ovary syndrome (PCOS). Developed by Razan Pharmed Iranian, the combination product contains myo-inositol, folate (as 5-methyltetrahydrofolate), vitamin E, alpha-lipoic acid, coenzyme Q10, and melatonin. Myo-inositol improves insulin sensitivity and ovarian function, while folate supports neural tube development and cellular division. The addition of potent antioxidants like vitamin E, alpha-lipoic acid, and coenzyme Q10 protects oocytes from oxidative stress, and melatonin helps regulate sleep cycles and supports oocyte maturation. Ozeele Plus is approved and marketed in Iran as an oral tablet or sachet.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ozeele Plus.